Guardant Health

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$191,476
$177,235
$168,491
$155,054
Gross Profit
191,476
104,814
103,195
236,189
EBITDA
-117,328
-89,918
-88,971
-252,524
EBIT
-100,618
-99,683
-263,392
Net Income
-107,754
-102,628
-114,985
-187,043
Net Change In Cash
191,476
177,235
168,491
155,054
Free Cash Flow
-55,258
-99,079
-37,218
-82,805
Cash
688,368
1,035,239
1,129,257
1,133,537
Basic Shares
123,051
122,447
121,712
118,508

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$563,948
$449,538
$373,653
$286,730
Gross Profit
336,896
293,213
250,741
194,195
EBITDA
-519,634
-650,872
-381,893
-241,138
EBIT
-562,515
-686,834
-404,164
-257,203
Net Income
-479,449
-654,588
-384,770
-246,283
Net Change In Cash
563,948
449,538
373,653
286,730
Cost of Revenue
-348,740
-338,996
689,294
Free Cash Flow
-345,461
-386,924
-284,052
-157,986
Cash
1,133,537
141,647
492,202
832,977
Basic Shares
111,988
102,178
101,314
97,504

Earnings Calls

Quarter EPS
2024-09-30
-$0.88
2024-06-30
-$0.84
2024-03-31
-$0.94
2023-12-31
-$0.85